A Study Evaluating TRIV-509 in Atopic Dermatitis
Running, not enrolling · Phase 2 · Has a placebo group
Conditions studied: Atopic Dermatitis
In brief
The goal of this interventional study is to learn if TRIV-509 works to treat moderate to severe atopic dermatitis in adults. It will also evaluate the safety of TRIV-509. Participants will receive 4 doses of the study intervention that they are randomized to (TRIV-509 or placebo), and at Week 16 will cross over and receive 4 doses of the other study intervention. The study duration for individual participants is up to 57 weeks, including a Screening period of up to 30 days.
Key facts
- Study ID
- NCT07167758
- Run by
- Triveni Bio
- People needed
- 95
- Starts
- 2025-08-26
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2026-04-27
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Has Atopic Dermatitis.
- Has moderate to severe, active and symptomatic AD
You may not qualify if…
- Severe or uncontrolled medical conditions.
- Use of topical treatments, phototherapy, systemic immunosuppressives or immunomodulatory therapies, or immunomodulatory biologics, within stated washout periods.
Where it is running
- Triveni Bio Site #11 — Fountain Valley, California, United States
- Triveni Bio Site #4 — San Diego, California, United States
- Triveni Bio Site #3 — Miami, Florida, United States
- Triveni Bio Site #6 — Indianapolis, Indiana, United States
- Triveni Bio Site #10 — South Bend, Indiana, United States
- Triveni Bio Site #1 — Camp Hill, Pennsylvania, United States
- Triveni Bio Site #16 — Bellaire, Texas, United States
- Triveni Bio Site #5 — Dallas, Texas, United States
- Triveni Bio Site #8 — Spokane, Washington, United States
- Triveni Bio Site #38 — Pleven, Bulgaria
- Triveni Bio Site #39 — Sofia, Bulgaria
- Triveni Bio Site #13 — Ajax, Ontario, Canada
- Triveni Bio Site #17 — Newmarket, Ontario, Canada
- Triveni Bio Site #12 — Niagara Falls, Ontario, Canada
- Triveni Bio Site #15 — North York, Ontario, Canada
- Triveni Bio Site #22 — Ostrava, Czechia
- Triveni Bio Site #31 — Pardubice, Czechia
- Triveni Bio Site #21 — Prague, Czechia
- Triveni Bio Site #37 — Prague, Czechia
- Triveni Bio Site #23 — Prague, Czechia
- Triveni Bio Site #41 — Budapest, Hungary
- Triveni Bio Site #34 — Budapest, Hungary
- Triveni Bio Site #43 — Debrecen, Hungary
- Triveni Bio Site #33 — Wroclaw, Lower Silesian Voivodeship, Poland
- Triveni Bio Site #28 — Warsaw, Masovian Voivodeship, Poland
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.